SP7 and diabetes mellitus: Meanwhile significantly lower numbers of Osterix+ osteoprogenitors (−30.75%, P=0.024) and Osteocalcin+ osteoblasts (−36.81%, P=0.031) were defined in the diabetes group than in non-diabetic group (Figure 5).